187 related articles for article (PubMed ID: 23656504)
1. In vitro evidence of the presence of mesenchymal stromal cells in cervical cancer and their role in protecting cancer cells from cytotoxic T cell activity.
Montesinos JJ; Mora-García Mde L; Mayani H; Flores-Figueroa E; García-Rocha R; Fajardo-Orduña GR; Castro-Manrreza ME; Weiss-Steider B; Monroy-García A
Stem Cells Dev; 2013 Sep; 22(18):2508-19. PubMed ID: 23656504
[TBL] [Abstract][Full Text] [Related]
2. Mesenchymal stromal cells derived from cervical cancer tumors induce TGF-β1 expression and IL-10 expression and secretion in the cervical cancer cells, resulting in protection from cytotoxic T cell activity.
García-Rocha R; Moreno-Lafont M; Mora-García ML; Weiss-Steider B; Montesinos JJ; Piña-Sánchez P; Monroy-García A
Cytokine; 2015 Dec; 76(2):382-390. PubMed ID: 26343835
[TBL] [Abstract][Full Text] [Related]
3. Mesenchymal Stem/Stromal Cells Derived from Cervical Cancer Promote M2 Macrophage Polarization.
Cortés-Morales VA; Chávez-Sánchez L; Rocha-Zavaleta L; Espíndola-Garibay S; Monroy-García A; Castro-Manrreza ME; Fajardo-Orduña GR; Apresa-García T; Gutiérrez-de la Barrera M; Mayani H; Montesinos JJ
Cells; 2023 Mar; 12(7):. PubMed ID: 37048119
[TBL] [Abstract][Full Text] [Related]
4. Mesenchymal Stromal Cells Derived from Normal Cervix and Cervical Cancer Tumors Increase CD73 Expression in Cervical Cancer Cells Through TGF-β1 Production.
Ávila-Ibarra LR; Mora-García ML; García-Rocha R; Hernández-Montes J; Weiss-Steider B; Montesinos JJ; Lizano Soberon M; García-López P; López CAD; Torres-Pineda DB; Chacón-Salinas R; Vallejo-Castillo L; Pérez-Tapia SM; Monroy-García A
Stem Cells Dev; 2019 Apr; 28(7):477-488. PubMed ID: 30696359
[TBL] [Abstract][Full Text] [Related]
5. Mesenchymal stromal cells derived from cervical cancer produce high amounts of adenosine to suppress cytotoxic T lymphocyte functions.
de Lourdes Mora-García M; García-Rocha R; Morales-Ramírez O; Montesinos JJ; Weiss-Steider B; Hernández-Montes J; Ávila-Ibarra LR; Don-López CA; Velasco-Velázquez MA; Gutiérrez-Serrano V; Monroy-García A
J Transl Med; 2016 Oct; 14(1):302. PubMed ID: 27782859
[TBL] [Abstract][Full Text] [Related]
6. Adenosine increases PD-L1 expression in mesenchymal stromal cells derived from cervical cancer through its interaction with A
Marín-Aquino LA; Mora-García ML; Moreno-Lafont MC; García-Rocha R; Montesinos-Montesinos JJ; López-Santiago R; Sánchez-Torres LE; Torres-Pineda DB; Weiss-Steider B; Hernández-Montes J; Don-López CA; Monroy-García A
Cell Biochem Funct; 2024 Apr; 42(3):e4010. PubMed ID: 38613217
[TBL] [Abstract][Full Text] [Related]
7. Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+CD25highFOXP3+ regulatory T cells.
Selmani Z; Naji A; Zidi I; Favier B; Gaiffe E; Obert L; Borg C; Saas P; Tiberghien P; Rouas-Freiss N; Carosella ED; Deschaseaux F
Stem Cells; 2008 Jan; 26(1):212-22. PubMed ID: 17932417
[TBL] [Abstract][Full Text] [Related]
8. Cervical cancer cells suppress effector functions of cytotoxic T cells through the adenosinergic pathway.
Mora-García ML; Ávila-Ibarra LR; García-Rocha R; Weiss-Steider B; Hernández-Montes J; Don-López CA; Gutiérrez-Serrano V; Titla-Vilchis IJ; Fuentes-Castañeda MC; Monroy-Mora A; Jave-Suárez LF; Chacón-Salinas R; Vallejo-Castillo L; Pérez-Tapia SM; Monroy-García A
Cell Immunol; 2017 Oct; 320():46-55. PubMed ID: 28950987
[TBL] [Abstract][Full Text] [Related]
9. Expression of CD56 by human papillomavirus E7-specific CD8+ cytotoxic T lymphocytes correlates with increased intracellular perforin expression and enhanced cytotoxicity against HLA-A2-matched cervical tumor cells.
Santin AD; Hermonat PL; Ravaggi A; Bellone S; Roman JJ; Jayaprabhu S; Pecorelli S; Parham GP; Cannon MJ
Clin Cancer Res; 2001 Mar; 7(3 Suppl):804s-810s. PubMed ID: 11300476
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of cell cycle and WNT pathway-related genes accounts for differences in the growth and differentiation potential of Wharton's jelly and bone marrow-derived mesenchymal stem cells.
Batsali AK; Pontikoglou C; Koutroulakis D; Pavlaki KI; Damianaki A; Mavroudi I; Alpantaki K; Kouvidi E; Kontakis G; Papadaki HA
Stem Cell Res Ther; 2017 Apr; 8(1):102. PubMed ID: 28446235
[TBL] [Abstract][Full Text] [Related]
11. Ex vivo immunosuppressive effects of mesenchymal stem cells on Crohn's disease mucosal T cells are largely dependent on indoleamine 2,3-dioxygenase activity and cell-cell contact.
Ciccocioppo R; Cangemi GC; Kruzliak P; Gallia A; Betti E; Badulli C; Martinetti M; Cervio M; Pecci A; Bozzi V; Dionigi P; Visai L; Gurrado A; Alvisi C; Picone C; Monti M; Bernardo ME; Gobbi P; Corazza GR
Stem Cell Res Ther; 2015 Jul; 6(1):137. PubMed ID: 26206376
[TBL] [Abstract][Full Text] [Related]
12. Adenosine augments the production of IL-10 in cervical cancer cells through interaction with the A
Torres-Pineda DB; Mora-García ML; García-Rocha R; Hernández-Montes J; Weiss-Steider B; Montesinos-Montesinos JJ; Don-López CA; Marín-Aquino LA; Muñóz-Godínez R; Ibarra LRÁ; López Romero R; Monroy-García A
Cytokine; 2020 Apr; 130():155082. PubMed ID: 32259773
[TBL] [Abstract][Full Text] [Related]
13. Microenvironment in neuroblastoma: isolation and characterization of tumor-derived mesenchymal stromal cells.
Pelizzo G; Veschi V; Mantelli M; Croce S; Di Benedetto V; D'Angelo P; Maltese A; Catenacci L; Apuzzo T; Scavo E; Moretta A; Todaro M; Stassi G; Avanzini MA; Calcaterra V
BMC Cancer; 2018 Nov; 18(1):1176. PubMed ID: 30482160
[TBL] [Abstract][Full Text] [Related]
14. Bone marrow-derived mesenchymal stem cells favor the immunosuppressive T cells skewing in a Helicobacter pylori model of gastric cancer.
Lin R; Ma H; Ding Z; Shi W; Qian W; Song J; Hou X
Stem Cells Dev; 2013 Nov; 22(21):2836-48. PubMed ID: 23777268
[TBL] [Abstract][Full Text] [Related]
15. Immunomodulatory effect of human bone marrow-derived mesenchymal stromal/stem cells on peripheral blood T cells from rheumatoid arthritis patients.
Pedrosa M; Gomes J; Laranjeira P; Duarte C; Pedreiro S; Antunes B; Ribeiro T; Santos F; Martinho A; Fardilha M; Domingues MR; Abecasis M; P da Silva JA; Paiva A
J Tissue Eng Regen Med; 2020 Jan; 14(1):16-28. PubMed ID: 31502378
[TBL] [Abstract][Full Text] [Related]
16. Direct T cell-tumour interaction triggers TH1 phenotype activation through the modification of the mesenchymal stromal cells transcriptional programme.
Jin P; Civini S; Zhao Y; De Giorgi V; Ren J; Sabatino M; Jin J; Wang H; Bedognetti D; Marincola F; Stroncek D
Br J Cancer; 2014 Jun; 110(12):2955-64. PubMed ID: 24809778
[TBL] [Abstract][Full Text] [Related]
17. Isolation of mesenchymal stromal cells (MSCs) from human adenoid tissue.
Lee YS; Lee JE; Park HY; Lim YS; Lee JC; Wang SG; Lee BJ
Cell Physiol Biochem; 2013; 31(4-5):513-24. PubMed ID: 23572135
[TBL] [Abstract][Full Text] [Related]
18. Derivation and immunological characterization of mesenchymal stromal cells from human embryonic stem cells.
Trivedi P; Hematti P
Exp Hematol; 2008 Mar; 36(3):350-9. PubMed ID: 18179856
[TBL] [Abstract][Full Text] [Related]
19. Mesenchymal stem cells generate a CD4+CD25+Foxp3+ regulatory T cell population during the differentiation process of Th1 and Th17 cells.
Luz-Crawford P; Kurte M; Bravo-Alegría J; Contreras R; Nova-Lamperti E; Tejedor G; Noël D; Jorgensen C; Figueroa F; Djouad F; Carrión F
Stem Cell Res Ther; 2013 Jun; 4(3):65. PubMed ID: 23734780
[TBL] [Abstract][Full Text] [Related]
20. Mesenchymal stem cells fail to trigger effector functions of cytotoxic T lymphocytes.
Rasmusson I; Uhlin M; Le Blanc K; Levitsky V
J Leukoc Biol; 2007 Oct; 82(4):887-93. PubMed ID: 17609339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
